In the third episode of the Idea to Patient podcast, our host Jenny Högblad, Clinical Trial Consultants (CTC) is joined by Suzanne Iverson Hemberg, Toxicology Knowledge Team and Bengt Danielsson, BeDa Consulting. They address a large and important part of drug development: the toxicological strategy. They talk about the design and evaluation of safety pharmacology and toxicology studies and why it is so important to get it right from the start.
The Idea to Patient podcast is available on Spotify and Apple Podcasts, and if you want to listen directly in your browser, click here .
Season 2, the Idea to Patient podcast, is recorded in collaboration with the CTR group and invites guests from the pharmaceutical industry to discuss the early stages of drug development – how to take your product from the idea stage all the way to clinical trials.
